Veeva Systems announced that ConvaTec has selected Veeva Vault CDMS to provide electronic data capture (EDC), coding, and data cleaning for their upcoming study on the detection of wound infections. To aid accurate and timely detection of wound infection in clinical practice, ConvaTec and partners have developed a new infection biomarker detection technology based on the combined measurement of the following three biomarkers: wound pH, activity of human neutrophil elastase (HNE), and myeloperoxidase (MPO) host enzymes. This proof-of-concept study will explore the effectiveness of a novel combination of biomarkers, pH, HNE, and MPO, in detecting wound infection. A secondary objective of the trial is to explore the relationship between molecular microbiological analysis of swab samples and wound biopsies with the biomarkers pH, HNE, and MPO. This is a multi-center, international, analytical performance study expected to take approximately 20 weeks to complete and aims to enroll between 75 and 90 subjects.